Wan et al. figured out that RNASE2 was identified as the valuable prognostic predictor in ccRCC patients and utilized to explore the occurrence mechanisms of renal carcinoma and to design individualized treatments for patients [33]. The gene discussed is RNASE2; the disease is nonpapillary renal cell carcinoma.